{"schema_version":"secwatch.filing_event.v1","accession":"0001367644-23-000075","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2023-03-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.638163+00:00","generated_at":"2026-06-17T17:50:36.776144+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Emergent BioSolutions eliminates Chief Strategy role; 2022 bonuses slashed below target","bullets":["Atul Saran departed as Chief Strategy Officer on March 17, 2023; receives severance per plan and RSU acceleration.","2022 NEO bonuses reduced due to below-target performance: CEO at 25%, others at 50% of target.","Actual annual incentives for NEOs ranged from 25% to 58% of target.","2023 base salaries set: CEO $1,032,500 (120% bonus target); CFO $615,000; COO/GC $585,000 each.","2023 equity grants limited by share availability; PSUs tied to cumulative revenue and Adjusted EBITDA Margin over 2023-2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001367644-23-000075","json":"https://secwatch.observer/filing/0001367644-23-000075.json","markdown":"https://secwatch.observer/filing/0001367644-23-000075.md","text":"https://secwatch.observer/filing/0001367644-23-000075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000075/0001367644-23-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000075/ebs-20230323.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T17:50:36.776144+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c70a7fe2e6","claim":"Atul Saran departed as Chief Strategy and Development Officer at Emergent BioSolutions Inc..","evidence_excerpt":"On March 17, 2023, in connection with the elimination of his position as Chief Strategy and Development Officer, the Company entered into a Separation Agreement (the “Separation Agreement”) with Atul Saran.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000075/0001367644-23-000075-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"departed"},{"label":"Role","value":"Chief Strategy and Development Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}